Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-06

FDA Approved: ADAPALENE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The U.S. FDA approved a supplemental application for Adapalene filed by Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene (Adapalene)

Snippet

SUPPL AP for ADAPALENE (ADAPALENE)